The global electric wheelchair market size is calculated at USD 41.56 billion in 2025 and is forecasted to reach around USD 66.33 billion by 2034, accelerating at a CAGR of 5.30% from 2025 to 2034. The North America electric wheelchair market size surpassed USD 17.02 billion in 2024 and is expanding at a CAGR of 5.33% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Electric Wheelchair Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Electric Wheelchair Market, by Product
8.1.1 Center Wheel Drive
8.1.1.1. Market Revenue and Forecast
8.1.2. Front Wheel Drive
8.1.2.1. Market Revenue and Forecast
8.1.3. Standing Electric Wheelchairs
8.1.3.1. Market Revenue and Forecast
8.1.4. Rear Wheel Drive
8.1.4.1. Market Revenue and Forecast
9.1. Electric Wheelchair Market, by End Users
9.1.1. Hospitals & Clinic
9.1.1.1. Market Revenue and Forecast
9.1.2. Home Care
9.1.2.1. Market Revenue and Forecast
9.1.3. Sports Conditioning
9.1.3.1. Market Revenue and Forecast
10.1. Electric Wheelchair Market, by Age Group
10.1.1. 60 years
10.1.1.1. Market Revenue and Forecast
10.1.2. 21 to <60 years
10.1.2.1. Market Revenue and Forecast
10.1.3. < 20 years
10.1.3.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product
11.1.2. Market Revenue and Forecast, by End Users
11.1.3. Market Revenue and Forecast, by Age Group
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product
11.1.4.2. Market Revenue and Forecast, by End Users
11.1.4.3. Market Revenue and Forecast, by Age Group
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product
11.1.5.2. Market Revenue and Forecast, by End Users
11.1.5.3. Market Revenue and Forecast, by Age Group
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product
11.2.2. Market Revenue and Forecast, by End Users
11.2.3. Market Revenue and Forecast, by Age Group
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product
11.2.4.2. Market Revenue and Forecast, by End Users
11.2.4.3. Market Revenue and Forecast, by Age Group
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product
11.2.5.2. Market Revenue and Forecast, by End Users
11.2.5.3. Market Revenue and Forecast, by Age Group
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product
11.2.6.2. Market Revenue and Forecast, by End Users
11.2.6.3. Market Revenue and Forecast, by Age Group
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product
11.2.7.2. Market Revenue and Forecast, by End Users
11.2.7.3. Market Revenue and Forecast, by Age Group
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product
11.3.2. Market Revenue and Forecast, by End Users
11.3.3. Market Revenue and Forecast, by Age Group
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product
11.3.4.2. Market Revenue and Forecast, by End Users
11.3.4.3. Market Revenue and Forecast, by Age Group
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product
11.3.5.2. Market Revenue and Forecast, by End Users
11.3.5.3. Market Revenue and Forecast, by Age Group
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product
11.3.6.2. Market Revenue and Forecast, by End Users
11.3.6.3. Market Revenue and Forecast, by Age Group
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product
11.3.7.2. Market Revenue and Forecast, by End Users
11.3.7.3. Market Revenue and Forecast, by Age Group
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product
11.4.2. Market Revenue and Forecast, by End Users
11.4.3. Market Revenue and Forecast, by Age Group
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product
11.4.4.2. Market Revenue and Forecast, by End Users
11.4.4.3. Market Revenue and Forecast, by Age Group
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product
11.4.5.2. Market Revenue and Forecast, by End Users
11.4.5.3. Market Revenue and Forecast, by Age Group
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product
11.4.6.2. Market Revenue and Forecast, by End Users
11.4.6.3. Market Revenue and Forecast, by Age Group
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product
11.4.7.2. Market Revenue and Forecast, by End Users
11.4.7.3. Market Revenue and Forecast, by Age Group
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product
11.5.2. Market Revenue and Forecast, by End Users
11.5.3. Market Revenue and Forecast, by Age Group
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product
11.5.4.2. Market Revenue and Forecast, by End Users
11.5.4.3. Market Revenue and Forecast, by Age Group
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product
11.5.5.2. Market Revenue and Forecast, by End Users
11.5.5.3. Market Revenue and Forecast, by Age Group
12.1. Matsunaga Manufactory Co., Ltd
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Meyra Group
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Invacare Corporation
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Karma Medical Products Co., Ltd
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Miki Kogyosho Co., Ltd
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Nissin Medical Industries Co., Ltd
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Pride Mobility Products Corp
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Sunrise Medical (U.S.) LLC
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Ottobock Se & Co Kgaa
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Permobil AB
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client